SPTB and histiocytic sarcoma: It should be mentioned that genetic analysis is not yet recommended for HS diagnosis, since hundreds of mutations exist; however, the finding of this, same SPTB mutation in a non-related patient of our cohort of patients with chronic hemolytic anemia due to HS [5] provides further support to its P-5 pathogenicity.